BioInvent International AB
STO:BINV
BioInvent International AB
Pre-Tax Income
BioInvent International AB
Pre-Tax Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BioInvent International AB
STO:BINV
|
Pre-Tax Income
-kr429.2m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-23%
|
|
|
Biogaia AB
STO:BIOG B
|
Pre-Tax Income
kr447.8m
|
CAGR 3-Years
21%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Pre-Tax Income
kr172.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Pre-Tax Income
kr674m
|
CAGR 3-Years
14%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Pre-Tax Income
kr4.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
BioArctic AB
STO:BIOA B
|
Pre-Tax Income
-kr189.5m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
BioInvent International AB
Glance View
BioInvent International AB engages in the research and development of novel and immuno-modulatory antibodies for the treatment of cancer. The company is headquartered in Lund, Skane and currently employs 84 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.
See Also
What is BioInvent International AB's Pre-Tax Income?
Pre-Tax Income
-429.2m
SEK
Based on the financial report for Dec 31, 2024, BioInvent International AB's Pre-Tax Income amounts to -429.2m SEK.
What is BioInvent International AB's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
-23%
Over the last year, the Pre-Tax Income growth was -30%. The average annual Pre-Tax Income growth rates for BioInvent International AB have been -16% over the past three years , -25% over the past five years , and -23% over the past ten years .
You don't have any saved screeners yet